You are viewing: India Therapeutic Hypothermia Systems Market analysis

The India Therapeutic Hypothermia Systems Market was valued at $5.9 Million in 2023 and projected to reach to $8.7 Million by 2028, representing a compound annual growth rate of 8.1%. India's therapeutic hypothermia systems market is poised for sustained expansion driven by increasing healthcare expenditure, rising prevalence of cardiac and neurological emergencies, and growing adoption of evidence-based critical care protocols.

India Therapeutic Hypothermia Systems Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Therapeutic Hypothermia Systems Market Trends and Insights

  • This expansion reflects India's increasing adoption of advanced critical care technologies and growing awareness of therapeutic hypothermia applications in cardiac arrest and neurological conditions.
  • India's healthcare infrastructure modernization and rising investment in hospital ICU capabilities are driving demand for these specialized cooling systems across major metropolitan and tier-2 cities. The market in India is characterized by growing penetration in tertiary care centers and emerging adoption in secondary hospitals.
  • India's expanding patient population and improving healthcare accessibility are creating opportunities for therapeutic hypothermia system manufacturers.
  • Between 2023 and 2028, India is expected to witness accelerated market growth as clinical evidence supporting hypothermia therapy gains traction among Indian healthcare providers and regulatory frameworks become more supportive of advanced therapeutic interventions..

Key Market Statistics

  • CAGR (2023-2028) 8.1% CAGR
  • Market Size, 2023 ~USD 5.9 Million
  • Forecast, 2028 ~USD 8.7 Million
  • Country India

India Therapeutic Hypothermia Systems Market Overview

Market Valuation Growth :

India's therapeutic hypothermia systems market reached USD 5.9 million in 2023 and is projected to grow to USD 8.7 million by 2028, representing a strong CAGR of 8.1%, outpacing the global growth rate of 6.3%.

Rising Critical Care Adoption :

Indian hospitals and healthcare facilities are increasingly investing in advanced critical care technologies, with therapeutic hypothermia systems gaining traction in intensive care units (ICUs) across major metropolitan and tier-2 cities.

Clinical Application Expansion :

Growing awareness among Indian healthcare professionals regarding therapeutic hypothermia's efficacy in treating cardiac arrest, traumatic brain injury, and neurological conditions is driving demand across private and government medical institutions.

Healthcare Infrastructure Modernization :

India's ongoing healthcare infrastructure development, coupled with government initiatives to upgrade medical facilities and increase ICU bed capacity, is creating favorable conditions for therapeutic hypothermia system deployment.

India Therapeutic Hypothermia Systems Market Dynamics

  • The market benefits from India's large patient population and expanding private healthcare sector investments in advanced medical technologies. Key growth catalysts include enhanced medical professional training in hypothermia therapy, improved reimbursement policies, and rising awareness among hospital administrators regarding patient outcomes.
  • As India's healthcare infrastructure continues modernizing and ICU capabilities expand across urban and semi-urban regions, demand for therapeutic hypothermia systems is expected to accelerate significantly through 2028..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • India's therapeutic hypothermia systems market is valued at USD 5.9 million in 2023 and is forecast to reach USD 8.7 million by 2028, representing an 8.1% CAGR.
    • India's market growth is driven by modernization of healthcare infrastructure, increased ICU investments, and rising awareness of therapeutic hypothermia benefits in critical care settings.
    • India's tertiary care centers and metropolitan hospitals are leading adoption, with emerging opportunities in secondary healthcare facilities across tier-2 and tier-3 cities.
    • India's expanding patient population and improving clinical evidence adoption position the country as a high-growth market within the Asia Pacific region through 2028.

    Therapeutic Hypothermia Systems Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment CARDIOLOGY (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 6.3% from 2023 to 2028
    Largest Segment COOLING DEVICES (Product)
    Market Size Base Year (Billions) ~USD 0.29 (2023)
    Revenue Forecast (Billions) ~USD 0.4 (2028)
    Segments Covered Product, Application, Volume

    India Therapeutic Hypothermia Systems Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Cool Caps
    • Cooling Catheters
    • Cooling Devices

    By Application

    • Cardiology
    • Neonatal Care
    • Neurology
    • Other Applications

    By Volume

    • Cooling Devices

    INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    CARDIOLOGY3.744.34.64.95.35.76.27.6
    NEONATAL CARE0.60.60.60.70.70.80.80.98.4
    NEUROLOGY4.24.655.35.86.26.87.27.6
    OTHER APPLICATIONS0.40.40.40.50.50.50.50.68.4
    TOTAL8.99.610.311.111.912.813.814.97.7

    Target Audience

    • Medical Device Manufacturers : Manufacturers of therapeutic hypothermia systems need India-specific market data to assess market size, growth trajectory, competitive positioning, and localization opportunities to establish or expand manufacturing and distribution operations in India.
    • Hospital Administrators & ICU Directors : Hospital decision-makers require market insights on therapeutic hypothermia adoption trends, clinical efficacy data, cost-benefit analysis, and peer institution investments to justify capital expenditures and technology procurement decisions.
    • Healthcare Investors & Private Equity : Investment firms evaluating opportunities in India's healthcare sector need comprehensive market analysis, growth projections, and competitive landscape data to identify high-potential therapeutic hypothermia companies and healthcare technology investments.
    • Clinical Research Organizations : CROs conducting trials or research on therapeutic hypothermia in India need market data on patient populations, hospital infrastructure, clinical adoption rates, and geographic distribution to design studies and identify research sites.
    • Healthcare Consultants & Strategy Firms : Consulting firms advising healthcare clients on market entry, product strategy, or portfolio expansion in India require detailed market segmentation, growth drivers, and competitive analysis specific to the therapeutic hypothermia systems sector.

    Reasons to Buy this Report

    • India-Specific Market Sizing : Access precise valuation data for India's therapeutic hypothermia market with verified 2023 baseline (USD 5.9M) and 2028 forecast (USD 8.7M), enabling accurate business planning and investment decisions specific to the Indian healthcare landscape.
    • Competitive Growth Intelligence : Understand India's 8.1% CAGR outperformance versus global 6.3% growth rate, identifying India as a high-priority market for expansion, partnerships, and product localization strategies within South Asia.
    • Healthcare Infrastructure Insights : Gain detailed understanding of India's critical care infrastructure modernization trends, ICU capacity expansion, and government healthcare initiatives that directly influence therapeutic hypothermia system adoption rates and market penetration opportunities.
    • Clinical Application Mapping : Identify specific clinical use cases driving demand in India including cardiac arrest management, traumatic brain injury treatment, and neurological care protocols, enabling targeted marketing and product development strategies.
    • Strategic Market Entry Planning : Leverage India-focused market analysis to develop go-to-market strategies, identify key hospital networks, assess reimbursement landscapes, and prioritize geographic expansion across metropolitan and tier-2 cities with highest growth potential.

    Frequently asked questions

    What is the current market size of therapeutic hypothermia systems in India?

    India's therapeutic hypothermia systems market was valued at USD 5.9 million in 2023 and is projected to grow to USD 8.7 million by 2028.

    What is the expected growth rate for India's therapeutic hypothermia systems market?

    India's therapeutic hypothermia systems market is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2023 to 2028.

    Which healthcare facilities in India are driving therapeutic hypothermia system adoption?

    India's tertiary care centers and metropolitan hospitals are the primary drivers of adoption, with emerging demand in secondary healthcare facilities across tier-2 and tier-3 cities.

    What factors are contributing to market growth in India?

    India's market growth is driven by healthcare infrastructure modernization, increased ICU investments, rising clinical awareness, and expanding patient populations requiring critical care interventions.

    How does India's market compare to the global therapeutic hypothermia systems market?

    India's market is growing at 8.1% CAGR, outpacing the global CAGR of 6.3%, positioning India as a high-growth market within the Asia Pacific region.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the therapeutic hypothermia systems market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as pharmaceutical & biotechnology industries, food & nutraceutical industries, and research laboratories) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Therapeutic Hypothermia  Systems Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various therapeutic hypothermia systems were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value therapeutic hypothermia systems market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of market at the regional and country level 
    • Relative adoption pattern of each market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level 

    Global Therapeutic Hypothermia Systems Market Size: Top-Down Approach

    Therapeutic Hypothermia  Systems Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Therapeutic Hypothermia Systems Market Size: Bottom-Up Approach

    Therapeutic Hypothermia  Systems Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Therapeutic hypothermia systems industry.

    Market Definition

    Therapeutic hypothermia, also known as targeted temperature management or induced hypothermia, is a medical treatment that involves lowering a patient’s body temperature for a specific period to provide therapeutic benefits. This intervention is often employed in certain medical conditions to reduce the risk of injury to tissues, particularly the brain, and improve overall outcomes. The primary goal of therapeutic hypothermia is to protect the body’s organs, especially the brain, from damage following events such as cardiac arrest, traumatic brain injury, stroke, or neonatal hypoxic-ischemic encephalopathy (a type of brain injury that occurs when there is a lack of oxygen and blood flow to the brain in newborns).

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • R&D Department
    • Surgeons and Anesthesiologists/Paramedical Staff/Nursing Staff

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the therapeutic hypothermia systems market by product, application, and region
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
    • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Rest of the world.
    • To profile key players in the market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the market.
    • To benchmark players within the market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Therapeutic hypothermia systems market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Therapeutic hypothermia systems Market

    Get the Full Therapeutic Hypothermia Systems Market Report

    Full forecast, segment splits, and company analysis for all Therapeutic Hypothermia Systems Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status